ChristopherTRitchlinMD

Rheumatology • Rochester, NY

Rheumatoid Arthritis & Related, Vasculitis

Professor, Medicine, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Ritchlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ritchlin's full profile

Already have an account?

Office
400 Red Creek Dr
Suite 240
Rochester, NY 14623
Phone+1 585-486-0901

Fax+1 585-340-5399

Education & Training

NYU Grossman School of MedicineFellowship, Rheumatology, 1986 - 1989
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1983 - 1985
Albany Medical CenterInternship, Internal Medicine, 1982 - 1983
Albany Medical CollegeClass of 1982

Certifications & Licensure

NY State Medical License 1984 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Fellow (FACR) American College of Rheumatology

Clinical Trials

Centocor Microarray Study of Patients Start of enrollment: 2007 Mar 01
Completed
Phase 4
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy Start of enrollment: 2009 Jul 01
Terminated
Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) Start of enrollment: 2010 Oct 01
Completed
National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study Start of enrollment: 2010 Jun 01
Completed
NIR Fluorescence Imaging of Lymphatic Transport Using ICG Start of enrollment: 2015 Dec 08
Completed
Phase 1
Teriparatide as a Chondroregenerative Therapy in OA Start of enrollment: 2017 May 01
Completed
Phase 2
Multi-Center PAMPA Study Start of enrollment: 2022 Feb 16
Recruiting
Phase 4
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

164 citations
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal
Arthritis Care & Research. 2019-01-01
8 citations
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from ...
Laura C Coates, Robert Landewé, Iain B McInnes, Philip J Mease, Christopher T Ritchlin
RMD Open. 2024-02-22
41 citations
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III ran...
Christopher T. Ritchlin, Philip S. Helliwell, Wolf-Henning Boehncke, Enrique R. Soriano, Elizabeth C. Hsia
RMD Open. 2021-02-01

Journal Articles

Psoriasis: Psychosomatic, Somatopsychic, or Both?
Chase W Kwon, Francisco Tausk, Christopher Ritchlin, ScienceDirect

Lectures

American College of Rheumatology (ACR): Winter Rheumatology Symposium
American College of Rheumatology(ACR), Snowmass, Colorado - 1/26/2013

Press Mentions

Meet the Professor: Axial SpondyloarthritisOctober 14th, 2024
Guselkumab Brings Active Psoriatic Arthritis into ‘Stringent’ Control Through 2 YearsJuly 11th, 2024
Good News on GuselkumabMay 26th, 2023
Join now to see all

Grant Support

Role Of B Cells In Synovial Inflammation &Ln Remodeling In RA ArthritisNational Institute Of Allergy And Infectious Diseases2010–2011
Osteoclastic Bone Resorption In Psoriatic ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2003

Professional Memberships

American College of Rheumatology - ACR
Fellow